Itziar Otano

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 13, 2023
At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC.

Itziar Otano, Alvaro C Ucero, Jon Zugazagoitia

|Dec 16, 2021
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation.

Itziar Otano, Arantza Azpilikueta, Javier Glez-Vaz

|Jun 14, 2019
Twists and turns to translating 4-1BB cancer immunotherapy.

Miguel F Sanmamed, Iñaki Etxeberría, Itziar Otano

|Jul 19, 2017
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis.

Harsimran D Singh, Itziar Otano, Krista Rombouts

Pageof 1